%0 Journal Article %1 samouha2021oncolytic %A Samouha, Avishai %A J Fogel, Elisha %A Goel, Sanjay %A Maitra, Radhashree %D 2021 %J Journal of Oncology Research and Therapy (ISSN: 2574-710X) %K CRC KRAS OncolyticVirus Reovirus Transcriptome %P 7 %R 10.29011/2574-710X.10118 %T Oncolytic Virus Affects the RAS Pathway in Cancer: RNA Sequence Analysis %U https://www.gavinpublishers.com/article/view/oncolytic-virus-affects-the-ras-pathway-in-cancer:-rna-sequence-analysis %V 5 %X Background: Approximately 45% of individuals diagnosed with Colorectal Cancer (CRC) also possess KRAS mutations. One developing therapeutic method for this disease is reovirus treatment. It is theorized that reovirus treatment on patients with KRAS mutated CRC cells would be successful due to the virus’ innate oncolytic properties 1. Reovirus, a stable form of nonenveloped double-stranded RNA, causes minor infections in humans under normal circumstances. However, when the virus encounters KRAS mutated cells, it has the potential to lyse them 2. While this method of treatment to CRC has shown signs of success, we are still some ways from universal administration of reovirus as a treatment. This review seeks to utilize various studies, as well as our original research data, to investigate reovirus as an efficient method of treatment, with a focus on select growth, apoptotic and RAS-related genes, and their effectiveness of mitigating KRAS mutated CRC post reovirus treatment. Furthermore, the review highlights transcriptome analysis as an effective tool to examine these genes and their activity. It has been shown that reovirus treatment induces apoptosis and mitigates growth related gene activity. Conclusions: This review confirms the novelty of our findings on the efficacy of reovirus in CRC treatment. The study that this review article discusses concluded that 10 apoptotic and lymphocyte-related genes were found to be upregulated and 6 angiogenesis and Ras-related genes were found to be downregulated post reovirus treatment. These findings enforce the notion that reovirus could be used as a novel treatment for KRAS mutated CRC.

@article{samouha2021oncolytic, abstract = {Background: Approximately 45% of individuals diagnosed with Colorectal Cancer (CRC) also possess KRAS mutations. One developing therapeutic method for this disease is reovirus treatment. It is theorized that reovirus treatment on patients with KRAS mutated CRC cells would be successful due to the virus’ innate oncolytic properties [1]. Reovirus, a stable form of nonenveloped double-stranded RNA, causes minor infections in humans under normal circumstances. However, when the virus encounters KRAS mutated cells, it has the potential to lyse them [2]. While this method of treatment to CRC has shown signs of success, we are still some ways from universal administration of reovirus as a treatment. This review seeks to utilize various studies, as well as our original research data, to investigate reovirus as an efficient method of treatment, with a focus on select growth, apoptotic and RAS-related genes, and their effectiveness of mitigating KRAS mutated CRC post reovirus treatment. Furthermore, the review highlights transcriptome analysis as an effective tool to examine these genes and their activity. It has been shown that reovirus treatment induces apoptosis and mitigates growth related gene activity. Conclusions: This review confirms the novelty of our findings on the efficacy of reovirus in CRC treatment. The study that this review article discusses concluded that 10 apoptotic and lymphocyte-related genes were found to be upregulated and 6 angiogenesis and Ras-related genes were found to be downregulated post reovirus treatment. These findings enforce the notion that reovirus could be used as a novel treatment for KRAS mutated CRC.}, added-at = {2021-11-24T12:28:59.000+0100}, author = {Samouha, Avishai and J Fogel, Elisha and Goel, Sanjay and Maitra, Radhashree}, biburl = {https://www.bibsonomy.org/bibtex/27d8cd6d219316584c61b872df64e7ab5/alyssacarter}, doi = {10.29011/2574-710X.10118}, interhash = {427147cf4524bb05cf3021d56551db17}, intrahash = {7d8cd6d219316584c61b872df64e7ab5}, issn = {2574-710X}, journal = {Journal of Oncology Research and Therapy (ISSN: 2574-710X)}, keywords = {CRC KRAS OncolyticVirus Reovirus Transcriptome}, language = {ENGLISH}, month = {October}, pages = 7, timestamp = {2021-11-24T12:28:59.000+0100}, title = {Oncolytic Virus Affects the RAS Pathway in Cancer: RNA Sequence Analysis}, url = {https://www.gavinpublishers.com/article/view/oncolytic-virus-affects-the-ras-pathway-in-cancer:-rna-sequence-analysis}, volume = 5, year = 2021 }